burkitt's lymphoma

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)

Completed
  • Burkitt's Lymphoma
  • +4 more
  • Frankfurt, Germany
    University Hospital, Medical Dept. II
Aug 17, 2022

HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)

Completed
  • HIV
  • Burkitt's Lymphoma
  • Induction Phase
  • +4 more
  • Aviano (PN), Italy
  • +7 more
Aug 2, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 4, 2021

Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)

Completed
  • Diffuse Large Cell Lymphoma
  • +2 more
  • Buffalo, New York
  • +4 more
Oct 29, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (HSC835)

Completed
  • Acute Myelocytic Leukemia
  • +12 more
  • HSC835
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (Rapamycin + high dose etoposide and cytarabine)

Terminated
  • ALL
  • +3 more
  • Rapamycin + high dose etoposide and cytarabine
  • Philadelphia, Pennsylvania
    University of Pennsylvania Abramson Cancer Center
Apr 15, 2020

Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)

Terminated
  • Acute Leukemias
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Dec 12, 2019

Burkitt's Lymphoma, Burkitt'S-like Lymphoma Trial in Houston (Rituximab, Cyclophosphamide, Doxorubicin)

Completed
  • Burkitt's Lymphoma
  • Burkitt'S-like Lymphoma
  • Houston, Texas
    The University of Texas M. D. Anderson Cancer Center
Apr 18, 2018

Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Burkitt's Lymphoma Trial in Mount Holly (Alisertib)

Completed
  • Diffuse Large B-cell Lymphoma
  • +4 more
  • Mount Holly, New Jersey
    Hematology Oncology Associates, Virtua Memorial Hospital Burling
Feb 27, 2018

DLBCL, Transformed Follicular Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Alisertib (MLN8237), Rituximab, Vincristine)

Completed
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Alisertib (MLN8237)
  • +2 more
  • Tucson, Arizona
  • +24 more
Feb 27, 2018

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Minneapolis (biological, drug, radiation)

Withdrawn
  • Hematologic Malignancy
  • +16 more
  • Treg cells
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 29, 2017

Rituximab-containing Immunochemotherapy for Burkitt's or

Completed
  • Burkitt's Lymphoma
  • High-grade B-cell Lymphoma
  • No intervention (observational study)
  • Incheon, Korea, Republic of
    Gachon University Gil Medical Center
Feb 22, 2017

Acute Lymphoblastic Leukemia, Burkitt's Lymphoma Trial in Spain (RITUXIMAB)

Completed
  • Acute Lymphoblastic Leukemia
  • Burkitt's Lymphoma
  • Alicante, Spain
  • +14 more
Oct 27, 2014